Troy A. Ignelzi - 21 Dec 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Issuer symbol
N/A
Transactions as of
21 Dec 2021
Net transactions value
+$64,124
Form type
4
Filing time
22 Dec 2021, 15:42:52 UTC
Previous filing
10 Nov 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $53,995 +5,869 +33% $9.20* 23,869 21 Dec 2021 Direct
transaction KRTX Common Stock Options Exercise $10,129 +1,101 +4.6% $9.20* 24,970 21 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -5,869 -3.5% $0.000000 160,356 21 Dec 2021 Common Stock 5,869 $9.20 Direct F1
transaction KRTX Option (right to buy) Options Exercise $0 -1,101 -11% $0.000000 8,930 21 Dec 2021 Common Stock 1,101 $9.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested and became exercisable as to 1/4th of the shares underlying the option award on March 1, 2020, and continues to vest as to an additional 1/8th of the shares on each six month anniversary thereafter.
F2 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on April 1, 2019.